115 related articles for article (PubMed ID: 21047774)
1. Clinical implications of the influence of Ehm2 on the aggressiveness of breast cancer cells through regulation of matrix metalloproteinase-9 expression.
Yu H; Ye L; Mansel RE; Zhang Y; Jiang WG
Mol Cancer Res; 2010 Nov; 8(11):1501-12. PubMed ID: 21047774
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein-10 (BMP-10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer.
Ye L; Bokobza S; Li J; Moazzam M; Chen J; Mansel RE; Jiang WG
Cancer Sci; 2010 Oct; 101(10):2137-44. PubMed ID: 20608934
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9.
Yuan Z; Sanders AJ; Ye L; Wang Y; Jiang WG
Oncol Rep; 2011 Jul; 26(1):237-45. PubMed ID: 21503589
[TBL] [Abstract][Full Text] [Related]
4. Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.
Cai W; Ye L; Sun J; Mansel RE; Jiang WG
Int J Mol Med; 2010 Apr; 25(4):573-80. PubMed ID: 20198306
[TBL] [Abstract][Full Text] [Related]
5. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
Parr C; Jiang WG
Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression.
Sun S; Ke Z; Wang F; Li S; Chen W; Han A; Wang Z; Shi H; Wang LT; Chen X
Hum Pathol; 2012 Jul; 43(7):1051-60. PubMed ID: 22204714
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
Mizuma M; Katayose Y; Yamamoto K; Shiraso S; Sasaki T; Yabuuchi S; Oda A; Masuda K; Rikiyama T; Onogawa T; Ohtsuka H; Motoi F; Egawa S; Unno M
Anticancer Res; 2008; 28(5A):2669-77. PubMed ID: 19035293
[TBL] [Abstract][Full Text] [Related]
8. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
Wu ZS; Wu Q; Wang CQ; Wang XN; Huang J; Zhao JJ; Mao SS; Zhang GH; Xu XC; Zhang N
Cancer; 2011 Jul; 117(13):2842-52. PubMed ID: 21692045
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the metastasis-associated gene Ehm2 in prostate cancer.
Wang J; Cai Y; Penland R; Chauhan S; Miesfeld RL; Ittmann M
Prostate; 2006 Nov; 66(15):1641-52. PubMed ID: 16927306
[TBL] [Abstract][Full Text] [Related]
10. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.
Yin Y; Sanders AJ; Jiang WG
Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791
[TBL] [Abstract][Full Text] [Related]
11. Claudin-16 reduces the aggressive behavior of human breast cancer cells.
Martin TA; Harrison GM; Watkins G; Jiang WG
J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037
[TBL] [Abstract][Full Text] [Related]
12. Expressed in high metastatic cells (Ehm2) is a positive regulator of keratinocyte adhesion and motility: The implication for wound healing.
Bosanquet DC; Ye L; Harding KG; Jiang WG
J Dermatol Sci; 2013 Aug; 71(2):115-21. PubMed ID: 23664528
[TBL] [Abstract][Full Text] [Related]
13. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
14. Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.
Cheng S; Douglas-Jones A; Yang X; Mansel RE; Jiang WG
Cancer Genomics Proteomics; 2010; 7(2):67-73. PubMed ID: 20335520
[TBL] [Abstract][Full Text] [Related]
15. Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.
Vashishta A; Ohri SS; Proctor M; Fusek M; Vetvicka V
Int J Oncol; 2007 May; 30(5):1223-30. PubMed ID: 17390025
[TBL] [Abstract][Full Text] [Related]
16. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
Sizemore S; Cicek M; Sizemore N; Ng KP; Casey G
Cancer Res; 2007 Jul; 67(13):6183-91. PubMed ID: 17616675
[TBL] [Abstract][Full Text] [Related]
17. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
18. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
19. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells.
Lee HS; Seo EY; Kang NE; Kim WK
J Nutr Biochem; 2008 May; 19(5):313-9. PubMed ID: 17683926
[TBL] [Abstract][Full Text] [Related]
20. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]